This trial will test if a yearly injection of romosozumab, followed by an infusion of zoledronic acid, can help treat and prevent bone loss in older women with osteoporosis who live in long-term care facilities.
- Osteoporotic Fractures
- Postmenopausal Osteoporosis
2 Primary · 0 Secondary · Reporting Duration: 24 months
Side Effects for
2 Treatment Groups
Romosozumab, then Zoledronic Acid
1 of 2
Placebo, then Zoledronic Acid
1 of 2
200 Total Participants · 2 Treatment Groups
Primary Treatment: Romosozumab · Has Placebo Group · Phase 4
Who is running the clinical trial?
Age 65+ · Female Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What potential health risks are associated with Romosozumab treatment?
"There is evidence for Romosozumab's safety, thus it has been given a score of 3. This treatment has already cleared Phase 4 trials and can be prescribed to patients in need." - Anonymous Online Contributor
Have previous investigations into Romosozumab been conducted?
"Currently, there are 46 active studies concerning Romosozumab with 10 trials in the third phase. The primary site for these clinical tests is Douliu, Yunlin County; yet, this medication has been trialled across 751 different locations worldwide." - Anonymous Online Contributor
How many patients have been enrolled in this clinical trial thus far?
"Affirmative, the information hosted on clinicaltrials.gov testifies that this experiment is recruiting participants at present. Initially posted on September 15th 2021, it has since been updated as recently as 7/9/2022 and requires 200 volunteers from 1 medical centre to participate." - Anonymous Online Contributor
What conditions does Romosozumab typically ameliorate?
"Romosozumab is a therapeutic agent used to combat glucocorticoids. Furthermore, it has been demonstrated to be effective in the treatment of solid tumors, malignant neoplasms, and osteoporosis." - Anonymous Online Contributor
Is this research endeavor presently welcoming participants?
"Affirmative. According to clinicaltrials.gov, this experiement is at present recruiting participants after being initially posted on September 15th 2021 and last edited on September 7th 2022. 200 individuals need to be enlisted from a single medical centre." - Anonymous Online Contributor